DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMLAMSRAFoundation

Chylothorax

Confirm pleural chyle biochemically, distinguish it from pseudochylothorax, find traumatic or non-traumatic causes, protect nutrition and immunity, and escalate a persistent leak to specialist lymphatic intervention.

!
Time-critical presentation

A large or rapidly accumulating chylothorax can cause severe breathlessness and hypoxaemia; postoperative output may also signal a substantial ongoing thoracic-duct injury. Stabilise breathing, use thoracic ultrasound, drain when clinically necessary through a pleural-capable team, quantify the loss and involve thoracic surgery, interventional radiology and specialist nutrition early. Do not wait for the fluid to look milky before acting on respiratory compromise.

Open the sections you need. The overview is shown first.
01OverviewDefinition, clinical context and the essential points that orientate the chapter.

The thoracic duct carries absorbed long-chain dietary lipid and lymph from much of the body to the venous circulation. A leak below the usual mid-thoracic crossing tends to produce a right-sided effusion and a leak above it tends to be left-sided, but anatomical variation makes this an unreliable diagnostic rule. Bilateral collections occur. Chyle may be creamy, serous or blood-stained, particularly during fasting or after surgery.

The diagnostic task has three parts: prove that the fluid is chyle, decide whether the mechanism is duct disruption or impaired lymphatic flow, and establish the physiological cost of the leak. A postoperative onset is often clear; an apparently spontaneous chylothorax needs cross-sectional imaging and a deliberate malignancy and central-vein review. Lymphatic imaging is reserved for unresolved anatomy or to plan intervention.

Management is individualised because evidence is limited and output varies with oral intake. Conservative nutritional measures can reduce lymph flow while the injury heals, but prolonged restriction or drainage can create serious malnutrition and immune depletion. An MDT should set a time-limited plan with escalation criteria rather than continuing ineffective conservative care indefinitely.

Key points

  • Chylothorax is lymph rich in chylomicrons entering the pleural space after disruption or obstruction of the thoracic lymphatic system; appearance alone cannot confirm it.
  • Pleural fluid triglyceride above 1.24 mmol/L supports chylothorax, and demonstration of chylomicrons by lipoprotein analysis is the reference test when biochemical results are equivocal.
  • Pseudochylothorax develops in a longstanding effusion, commonly with tuberculosis or rheumatoid pleuritis, and is characterised by high cholesterol, cholesterol crystals and absent chylomicrons.
  • Recent oesophageal, mediastinal, cardiac or neck surgery and thoracic trauma point to duct injury; without trauma, search particularly for lymphoma, other malignancy, central venous obstruction and lymphatic disease.
  • Measure drain output and nutritional consequences rather than repeatedly discarding fluid without a plan; ongoing chyle loss depletes calories, fat, fat-soluble vitamins, lymphocytes and immunoglobulins.
  • A specialist dietitian may use a low-long-chain-fat diet with medium-chain triglyceride supplementation, enteral modification or parenteral nutrition according to leak severity and the patient's wider needs.
  • Treat the driver as well as the collection: oncological therapy, relief of venous obstruction or management of lymphangioleiomyomatosis can be as important as pleural drainage.
  • Persistent or clinically important leakage should be discussed for lymphatic imaging, thoracic-duct embolisation or surgical ligation; availability, timing and thresholds vary between expert centres.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
01

Thoracic duct injury

Thoracic surgery, central venous procedures and blunt or penetrating trauma can disrupt the duct or its tributaries and leak chyle into pleura.

02

Malignancy

Lymphoma and other mediastinal cancers obstruct or invade lymphatic pathways and are important non-traumatic causes in adults.

03

Lymphatic disorders

Congenital lymphatic abnormalities and rare diffuse lymphatic diseases can cause spontaneous or recurrent chyle leakage, with the final risk shaped by exposure and individual susceptibility.

04

Raised lymphatic pressure

Central venous thrombosis, cirrhosis and other causes of impaired thoracic lymph drainage can produce chylous effusion without direct duct rupture.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
  1. 1
    Lymphatic disruption

    Damage or obstruction raises pressure within the thoracic duct and allows intestinal lymph to escape through a defect.

  2. 2
    Pleural accumulation

    Triglyceride-rich chyle collects in one or both pleural spaces, with appearance influenced by recent dietary fat intake and fasting.

  3. 3
    Lung compression

    Increasing fluid compresses adjacent lung, reduces ventilated volume and causes breathlessness or hypoxaemia according to the patient's reserve.

  4. 4
    Systemic nutrient loss

    Persistent drainage removes fat, protein, electrolytes, immunoglobulins and lymphocytes, impairing nutrition and immune competence, thereby altering ventilation, gas transfer or respiratory mechanics.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Postoperative leakRed flag

New pleural drainage that increases or becomes creamy after enteral feeding following oesophagectomy, mediastinal surgery, cardiac surgery or neck dissection is highly suggestive. Record the operation, side, daily volume and relation to feeding.

Non-traumatic chylothorax

Progressive breathlessness with a unilateral or bilateral effusion, lymphadenopathy, weight loss, venous thrombosis or features of a lymphatic disorder should prompt investigation for lymphoma, metastatic malignancy and impaired central lymphatic drainage.

Respiratory compromiseRed flag

Tachypnoea, hypoxaemia, inability to lie flat or mediastinal displacement from a large collection requires urgent ultrasound-guided therapeutic drainage assessment, irrespective of whether lipid testing has returned.

Nutritional and immune loss

Weight loss, weakness, low albumin, electrolyte disturbance and lymphopenia can emerge during a sustained high-output leak. Recurrent infection may reflect both the underlying condition and loss of immune components.

Pseudochylothorax clue

A chronic calcified or thickened pleura with rheumatoid disease or previous tuberculosis favours a cholesterol-rich pseudochylous collection; it is a different process and thoracic-duct intervention is not its treatment.

05InvestigationsWhat to request, why it matters and how to interpret it.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Thoracic ultrasound and chest imagingFirst step
    Why
    Confirm a safely accessible effusion, identify septation and guide sampling or drainage.
    Interpretation and limitations
    Ultrasound establishes fluid and procedural anatomy but not chyle. Chest radiography follows size; contrast CT assesses mediastinum, lymph nodes, tumour, venous obstruction and alternative pleural pathology.
  2. 02
    Pleural triglyceride and cholesterol
    Why
    Separate a chylous from a cholesterol-rich chronic effusion.
    Interpretation and limitations
    BTS tables describe triglyceride above 1.24 mmol/L with low cholesterol as typical of chylothorax. High cholesterol above 5.18 mmol/L with low triglyceride and crystals supports pseudochylothorax. Fasting can make lipid results less clear.
  3. 03
    Pleural chylomicrons
    Why
    Confirm that the fluid contains intestinally absorbed chyle when routine lipid results or appearance are inconclusive.
    Interpretation and limitations
    Chylomicrons support true chylothorax; their absence with cholesterol crystals points away from a thoracic-duct leak. Liaise with the laboratory before sampling because specialist analysis may be sent away.
  4. 04
    Complete pleural-fluid assessment
    Why
    Avoid missing infection, malignancy or a second process in the same collection.
    Interpretation and limitations
    Send cell count and differential, protein and LDH with paired serum values, microbiology and cytology according to context. Chyle is often lymphocyte predominant, but that finding is not specific.
  5. 05
    Blood and nutritional profile
    Why
    Quantify consequences and prepare a safe nutritional strategy.
    Interpretation and limitations
    Trend FBC with lymphocytes, U&E, calcium, magnesium, phosphate, LFT, albumin, weight and dietetic assessment. Selected prolonged leaks need immunoglobulin and fat-soluble-vitamin review under specialist advice.
  6. 06
    Lymphatic imaging
    Why
    Locate abnormal flow or a leak and plan embolisation or surgery when initial care fails.
    Interpretation and limitations
    Lymphangiography, lymphoscintigraphy or dynamic contrast-enhanced MR lymphangiography is selected by the regional service. A non-visualised duct does not remove the need to treat ongoing clinically important loss.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
01

Pseudochylothorax

A long-standing inflammatory effusion rich in cholesterol can also appear milky; lipid analysis and crystals distinguish it from true chyle.

02

Empyema

Turbid pus may resemble chyle, but infection features, pleural pH, microscopy and separation after centrifugation support empyema.

03

Haemothorax

Blood-stained pleural fluid after trauma or surgery requires fluid haematocrit assessment and urgent consideration of active bleeding.

04

Other exudative effusion

Malignant or inflammatory serous fluid may be cloudy without chylomicrons; pleural biochemistry and cytology identify the broader process.

07ManagementImmediate care, first-line treatment, alternatives and escalation.
01ConfirmProve chyle and define the causeFirst stepMilky fluid, an unexplained lymphocytic effusion or new output after thoracic or neck surgery.
  1. 1Use thoracic ultrasound for aspiration, send triglyceride and cholesterol, and request chylomicron analysis when the biochemical pattern is borderline or clinical suspicion remains high.
  2. 2Build a timeline around surgery, trauma, feeding and central venous access; examine for lymphadenopathy and review for lymphoma, other cancer, venous thrombosis, cirrhosis, tuberculosis and lymphatic disorders.
  3. 3Obtain contrast-enhanced cross-sectional imaging unless the postoperative anatomy and immediate management are already clear, then discuss unexplained cases with a specialist pleural and lymphatic MDT.
02ConserveReduce flow without causing depletionThe patient is stable and a time-limited conservative trial is clinically reasonable.
  1. 1Drain only for symptoms or as required by the postoperative plan, and chart the true daily volume with oral or enteral intake so response can be judged meaningfully.
  2. 2AlternativeAsk a specialist dietitian to choose a low-long-chain-fat, medium-chain-triglyceride-enriched approach or temporary alternative nutrition; do not improvise a prolonged fat-free diet.
  3. 3Replace fluid and micronutrient deficits according to measured need, treat the underlying disorder and review progress frequently against agreed output, respiratory and nutritional endpoints.
03EscalateControl a persistent lymphatic leakEscalationOutput remains clinically important, nutrition deteriorates, re-accumulation causes symptoms or conservative treatment is unlikely to work.
  1. 1EscalationRefer early to thoracic surgery and a centre providing interventional lymphatic imaging; escalation depends on cause, output trend, operative risk and local capability rather than a universal single-day threshold.
  2. 2Consider percutaneous thoracic-duct embolisation within current NICE governance and expert consent, or surgical ligation when anatomy, urgency or failed radiological treatment makes surgery preferable.
  3. 3After intervention, confirm falling output, advance nutrition in a controlled manner, image for recurrence and retain follow-up for the causative malignancy, venous or lymphatic disease.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions
May reduce gastrointestinal secretion and lymph flow while nutritional and definitive leak-control measures are organised.

Octreotide as an adjunct in selected chyle leaks

There is no nationally standard adult chylothorax regimen. If used, prescribe an expert-centre protocol with pharmacy review and a documented output-based stop rule; use is off-label.

Evidence is limited and it must not delay embolisation or surgery when loss persists. Monitor glucose, gastrointestinal effects, gallbladder risk, pulse and relevant interactions; dosing varies with route, organ function and local experience.

08ComplicationsImportant consequences, why they occur and why they matter clinically.
01

Respiratory compromise

A large or recurrent collection restricts lung expansion and can worsen oxygenation, particularly after thoracic surgery or in underlying lung disease.

02

Protein-calorie malnutrition

Continuing chyle loss depletes calories, essential fats and protein, delaying wound healing and recovery, with severity determined by its extent and the patient's underlying reserve.

03

Immune depletion

Loss of lymphocytes and immunoglobulins weakens host defence and increases vulnerability to infection during prolonged leakage.

04

Electrolyte and volume disturbance

High-output loss can cause dehydration and biochemical abnormalities, especially when repeated drainage is needed, creating an additional need for recognition and targeted treatment.

05

Persistent fistula

Failure of the leak to close may require lymphatic imaging, embolisation or surgery and prolong hospitalisation.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.
  • Chart pleural drain volume and character every day, together with feeding route and fat exposure, because output without intake context can be misleading.
  • Track respiratory symptoms, oxygen requirement, radiographic re-accumulation and drain function; an abrupt fall may indicate blockage rather than healing.
  • Measure weight, fluid balance, albumin, renal function, electrolytes, calcium, magnesium, phosphate and lymphocyte count at a frequency proportionate to ongoing loss.
  • Reassess the conservative strategy at explicit MDT checkpoints and bring intervention forward if depletion, infection, prolonged admission or repeated procedures are accumulating.
  • After embolisation or ligation, supervise dietary progression and arrange imaging and cause-specific surveillance rather than assuming technical success equals cure.
10Special situationsVariants, exceptions and circumstances that change the usual approach.

Milky is not mandatory

Fasting, low oral intake or admixture with blood can make genuine chyle non-milky. Conversely, empyema and cholesterol-rich fluid may look creamy without containing chylomicrons.

Medium-chain fat takes another route

Medium-chain triglycerides are absorbed mainly into portal blood rather than packaged as intestinal chylomicrons, which can reduce but not abolish thoracic-duct flow.

Lymphoma deserves deliberate exclusion

Among non-traumatic causes, lymphoma is particularly important; cytology alone may be insufficient, so imaging, flow cytometry or tissue should be selected from the clinical picture.

A drain can hide the harm

A clear radiograph while litres of nutrient-rich fluid leave the body is not recovery. Output, replacement needs and the probability of spontaneous closure must drive decisions.

11Common pitfallsFrequent interpretation and management errors.
  1. 01

    Diagnosing chylothorax from colour without pleural lipid testing or chylomicron confirmation when needed.

  2. 02

    Confusing pseudochylothorax with a thoracic-duct leak and sending the patient for inappropriate lymphatic intervention.

  3. 03

    Continuing unrestricted chest drainage while failing to count calories, lymphocytes, electrolytes and protein loss.

  4. 04

    Using an improvised fat-free diet without a specialist dietitian or a defined duration and nutritional replacement plan.

  5. 05

    Repeatedly extending conservative care despite persistent clinically important output and a worsening nutritional trajectory.

Practice

Two practice questions

Question 1 of 20 correct
RespiratoryOriginal SBA

Confirming pleural chyle

Five days after oesophagectomy, a patient's chest drain becomes cloudy after enteral feeding. Pleural triglyceride is 1.5 mmol/L and cholesterol is low. Which interpretation is most appropriate?

Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom